Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title	Grant Number Sort descending	Program Official
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	5R01CA283687-02	Guillermo Marquez, Ph.D.
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Peptide multimer for early detection of hepatocellular carcinoma	5R01CA285303-02	Guillermo Marquez, Ph.D.
Torres, Keila Enitt	University Of Tx Md Anderson Can Ctr United States	Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs	5R01CA285980-02	Guillermo Marquez, Ph.D.
Klein, Alison P	Johns Hopkins University United States	Improving Management of patients at High Risk of Pancreatic Cancer	5R01CA299421-02	Matthew Young, Ph.D.
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	Matthew Young, Ph.D.
Borges, Chad R	Arizona State University-Tempe Campus United States	Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions	5R21CA269091-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02	Guillermo Marquez, Ph.D.
Storz, Peter	Mayo Clinic Jacksonville United States	Deiminated molecules as markers for developing pancreatic cancer - A1	5R21CA279916-02	Matthew Young, Ph.D.
Fuschiotti, Patrizia	University Of Pittsburgh At Pittsburgh United States	Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides	5R21CA280445-02	Wendy Wang, Ph.D., M.Sc.
Alambeigi, Farshid	University Of Texas At Austin United States	A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps	5R21CA280747-02	Matthew Young, Ph.D.
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	5R21CA282380-02	Wendy Wang, Ph.D., M.Sc.
Li, Feng	University Of California Los Angeles United States	Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer.	5R21CA283665-02	Guillermo Marquez, Ph.D.
Lesch, Bluma J	Yale University United States	Defining signatures of epigenetic sensitization to lung cancer in a mouse model	5R21CA288677-02	Guillermo Marquez, Ph.D.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	5R21CA296671-02	Matthew Young, Ph.D.
Wang, Tza-Huei Jeff	Johns Hopkins University United States	A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies	5R33CA272321-03	Christos Patriotis, Ph.D., M.Sc.